Month: September 2021

Gastric Plexiform Fibromyxoma in Children – A New Case Report and Review of Pediatric Literature

1. Abstract 1.1. Introduction: Plexiform Fibromyxoma (PF), also known as plexiform angiomyxoid myofibroblastic tumour (PAMT) is a rare mesenchymal myxoid tumour originating in different areas of the digestive system. Symptoms and signs are usually elusive: the most common are abdominal discomfort, dyspepsia, nausea and gastrointestinal bleeding with anemia and hematemesis.

Evaluation of Predicting Factors on Patients’ Outcome Underwent Esophageal Cancer Surgery Treatment, A Single Institution, A Decade of Study, Firoozgar Hospital, Tehran, Iran 2008-2019

1. Abstract 1.1. Background and Objectives: Esophagheal cancer is one of the deadliest cancers, because in addition to its high prevalence, mortality rate is also high and puts it at the sixth place in terms of mortality. The most commonly used treatment in these patients is surgery. People with tumors in higher stages may also …

Evaluation of Predicting Factors on Patients’ Outcome Underwent Esophageal Cancer Surgery Treatment, A Single Institution, A Decade of Study, Firoozgar Hospital, Tehran, Iran 2008-2019 Read More »

Outcomes of COVID-19 in Liver Transplant Recipients: A Single Center Experience

1. Abstract 1.1. Aim: COVID-19 pandemia has a significant negative influence on liver transplantation. The transplantation centers has used different managment protocols to overcome this public health concern. Data about COVID-19 in liver transplant recipients bases on limited availability of studies. We reported herein our institutional experience to contribute collecting data to achieve more precise …

Outcomes of COVID-19 in Liver Transplant Recipients: A Single Center Experience Read More »

Adverse Event Severity Grading System Applied to Percutaneous Transhepatic Biliary Metal Stenting as A One- or Two-Stage Procedure in Patients with Unresectable Malignant Extrahepatic Bile Duct Obstruction

1. Abstract 1.1. Aims: Percutaneous transhepatic biliary stenting (PTBS) can be associated with adverse events (AEs) of different severities. AEs might be assessed by a standardized AE severity grading system. The aim of this study was to compare the severity of adverse events in the 30-day interval after PTBS as a one- or two-stage procedure …

Adverse Event Severity Grading System Applied to Percutaneous Transhepatic Biliary Metal Stenting as A One- or Two-Stage Procedure in Patients with Unresectable Malignant Extrahepatic Bile Duct Obstruction Read More »